Mylan

Pharmaceuticals

Established in 1982. Makers of generic medicines. Alphapharm is the largest supplier of medicines to the government subsidised Pharmaceutical Benefits Scheme. Operates a manufacturing plant in Queensland. Acquired by Mylan in 2007. Bought Aspen's portfolio of prescription and over-the-counter products in Australia for $188 million in 2019.

Pharmaceutical manufacturer and marketer

Products are prescription and OTC (over the counter) drugs. Main focus is on sales and marketing and as they do not develop early stage new products, new product growth is by acquisition. Products are sold in more than 150 countries, with own sales companies in 60 countries. Product areas are respiratory, dermatological and pain/inflammation. Acquired by Mylan in 2016.

Pharmaceutical sales and marketing

Over the counter products are Azep and Eyezep (allergic Rhinitis), Linicin (head lice), Molaxole (constipation), Waxsol (ear wax).

Pharmaceuticals

Created in 2020 when Mylan merged with Pfizer's off-patent drug business, Upjohn.